Streetbeat News

Analyst Ratings

CBAY

Over the past 3 months, 7 analysts have published their opinion on CymaBay Therapeutics (NASDAQ:CBAY) stock. The majority of these analysts are bullish, with 5 giving a bullish rating and 2 somewhat bullish. The average 12-month price target for the stock is $14.86, which has increased by 14.31% over the past month.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 3:00 pm

XPEV

XPeng Inc - ADR (NYSE:XPEV) shares dropped by 13.7% after UBS downgraded the stock from Buy to Neutral. This follows a 57% rally last week when XPeng announced a strategic partnership with the Volkswagen Group. Volkswagen will purchase 4.99% of XPENG's outstanding shares at $15 per share, totaling approximately $700 million. The two companies will jointly develop two B-class battery electric vehicles for sale in China under the Volkswagen brand.

Portfolio Pulse from Henry Khederian

July 31, 2023 | 3:00 pm

RL

Ralph Lauren (NYSE:RL) has received 9 analyst ratings in the last quarter, with 2 being bullish, 6 somewhat bullish, and 1 indifferent. The average price target is $144.44, indicating potential upside from the current price of $131.145. The average has increased by 0.31% from the previous target of $144.00.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 3:00 pm

EXP

Truist Securities analyst Keith Hughes has maintained a 'Buy' rating on Eagle Materials (NYSE:EXP) and raised the price target from $195 to $220.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 2:54 pm

PLTR

Shares of Palantir Technologies, Inc. (NYSE:PLTR) are trading higher on above-average volume, continuing the upward momentum from last week. This follows an Outperform rating and $25 price target from Wedbush analyst Dan Ives. The stock is trending among retail investors on StockTwits and Yahoo! Finance. Palantir is set to release its Q2 financial results on August 7, with an expected EPS of 5 cents and revenue of $529.94 million.

Portfolio Pulse from Erica Kollmann

July 31, 2023 | 2:54 pm

CVX

Truist Securities analyst Neal Dingmann maintains a 'Hold' rating on Chevron (NYSE:CVX) and raises the price target from $163 to $165.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 2:53 pm

BAH

Truist Securities analyst Tobey Sommer has maintained a 'Hold' rating on Booz Allen Hamilton (NYSE:BAH) and raised the price target from $106 to $120.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 2:53 pm

INTU

RKT

Rocket Companies, Inc (NYSE:RKT) has announced the appointment of Varun Krishna as the new CEO, effective from September 5, 2023. Krishna, who has over 20 years of experience in fintech, will succeed Bill Emerson, the interim CEO. Emerson will continue in his role until Krishna joins and will remain on the board to ensure a smooth transition. Krishna previously served as Executive Vice President and General Manager, Consumer Group of Intuit Inc (NASDAQ:INTU). Rocket Companies' stock has gained 57% year-to-date.

Portfolio Pulse from Anusuya Lahiri

July 31, 2023 | 2:52 pm

ABCB

Truist Securities analyst Brandon King maintains a 'Buy' rating on Ameris (NASDAQ:ABCB) and raises the price target from $38 to $48.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 2:52 pm

AMAT

A significant bullish stance has been taken on Applied Mat (NASDAQ:AMAT) by a large investor, as indicated by a large position in the company's options. The sentiment among these big-money traders is split between 61% bullish and 38% bearish. The whales have been targeting a price range from $135.0 to $155.0 for Applied Mat over the last 3 months. B of A Securities, Mizuho, and Citigroup have all maintained their Buy rating on Applied Mat, with price targets of $165, $152, and $170 respectively.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 2:47 pm